Fig. 2
From: Refining mutanome-based individualised immunotherapy of melanoma using artificial intelligence
Overview of mutanome-based immunotherapy for malignant melanoma. DNA, deoxyribonucleic acid; RNA, ribonucleic acid; T-VEC, talimogene laherparepvec; GM-CSF, granulocyte macrophage colony stimulating factor; HSV-1, herpes simplex virus-1; NGS, Next Genome Sequencing; BAM, binary alignment map; VCF, variant cell format; SNP, single nucleotide polymorphism; shRNA, small hairpin RNA; cDNA, complementary DNA